NoyMed

Executive Summary

NoyMed is a global niche biometrics contract research organization (CRO) headquartered in Vilnius, Lithuania, founded in 2016. The company provides end-to-end clinical trial solutions, including biostatistics, SAS programming, data management, pharmacovigilance, and medical writing, primarily serving pharmaceutical, biotechnology, and medical device companies. With offices in the US and Armenia, NoyMed supports Phase I-IV trials across multiple therapeutic areas. As a private, bootstrapped CRO, NoyMed differentiates itself through specialized biometrics expertise and a global operational footprint. The company is positioned to benefit from the growing trend of pharmaceutical companies outsourcing clinical trial functions. While NoyMed operates in a competitive landscape, its niche focus and established capabilities provide a solid foundation for continued growth. However, as a smaller player, it may face challenges in scaling and competing with larger CROs. Overall, NoyMed represents a potential high-growth opportunity in the CRO space, with upside driven by new client acquisitions and expansion into emerging markets.

Upcoming Catalysts (preview)

• Q2 2026Major Pharmaceutical Client Win60% success
• Q3 2026Geographic Expansion into Asia or Latin America40% success
• H2 2026Strategic Partnership or Acquisition by a Larger CRO30% success